Matches in Wikidata for { <http://www.wikidata.org/entity/Q64803839> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q64803839 description "clinical trial" @default.
- Q64803839 description "ensayu clínicu" @default.
- Q64803839 description "klinisch onderzoek" @default.
- Q64803839 description "клінічне випробування" @default.
- Q64803839 name "Treatment Outcomes in Chronic Hepatitis B Patients on Sequential Therapy With Tenofovir Alafenamide (TAF)" @default.
- Q64803839 type Item @default.
- Q64803839 label "Treatment Outcomes in Chronic Hepatitis B Patients on Sequential Therapy With Tenofovir Alafenamide (TAF)" @default.
- Q64803839 prefLabel "Treatment Outcomes in Chronic Hepatitis B Patients on Sequential Therapy With Tenofovir Alafenamide (TAF)" @default.
- Q64803839 P1050 Q64803839-89257228-A339-4F24-A3F5-09A89E082A8A @default.
- Q64803839 P1050 Q64803839-D044F7FC-D514-41FE-8183-4D31073EE2D0 @default.
- Q64803839 P1050 Q64803839-D63DB144-0AF7-4BE9-941C-FB6AFA9A75F6 @default.
- Q64803839 P1132 Q64803839-299910CD-50C5-47DD-A3C7-622926342B1E @default.
- Q64803839 P1476 Q64803839-32B4E38A-4BBD-4C2C-8107-00855D69D895 @default.
- Q64803839 P17 Q64803839-4CC14DF7-AECC-480D-ADBC-05FF3516897E @default.
- Q64803839 P17 Q64803839-9920EE04-6197-488C-94E9-3C23B7AE2547 @default.
- Q64803839 P17 Q64803839-BB7A2CB9-6925-47EE-859C-6BC82B4C6E0B @default.
- Q64803839 P2899 Q64803839-F6891A45-E4B7-47C9-9C40-0A5AE1DCB63A @default.
- Q64803839 P3098 Q64803839-BFF3C677-1BF8-4D28-994B-C897CCF1003C @default.
- Q64803839 P31 Q64803839-E3260BA8-C970-4EC4-9E9D-304093B8F9E2 @default.
- Q64803839 P580 Q64803839-CC8619B9-A976-4E83-B493-ABB2424CFD63 @default.
- Q64803839 P582 Q64803839-8ED96856-1403-40C4-82E5-3EE15F7F08E3 @default.
- Q64803839 P6099 Q64803839-E7BF0EA9-577E-4F30-9A12-44B8FDA56DF8 @default.
- Q64803839 P6153 Q64803839-19297792-6E75-45F6-A3BF-D159D207C2D2 @default.
- Q64803839 P6153 Q64803839-1E5BC5F8-2047-42E9-BC79-19A0FD3D9B87 @default.
- Q64803839 P6153 Q64803839-25E0AE2A-C06E-48CB-8017-AD6E77653F68 @default.
- Q64803839 P6153 Q64803839-5006E6E6-C34E-430C-BAD9-9E1962A3BC99 @default.
- Q64803839 P6153 Q64803839-6F9CCA2F-4FDF-4BC2-BFC3-CD07D3D9A7E9 @default.
- Q64803839 P6153 Q64803839-B6D3CE32-76CD-48FD-A0EC-43554CBA0E3E @default.
- Q64803839 P6153 Q64803839-C12E0709-FB39-4375-B9AB-F674AA819644 @default.
- Q64803839 P8363 Q64803839-A27BF7C9-F7E7-4F40-9048-89BE998AB08B @default.
- Q64803839 P1050 Q131742 @default.
- Q64803839 P1050 Q157661 @default.
- Q64803839 P1050 Q6853 @default.
- Q64803839 P1132 "+251" @default.
- Q64803839 P1476 "Treatment Outcomes in Chronic Hepatitis B Patients on Sequential Therapy With Tenofovir Alafenamide (TAF)" @default.
- Q64803839 P17 Q17 @default.
- Q64803839 P17 Q30 @default.
- Q64803839 P17 Q865 @default.
- Q64803839 P2899 "+18" @default.
- Q64803839 P3098 "NCT03471624" @default.
- Q64803839 P31 Q30612 @default.
- Q64803839 P580 "2018-05-01T00:00:00Z" @default.
- Q64803839 P582 "2020-04-01T00:00:00Z" @default.
- Q64803839 P6099 Q42825046 @default.
- Q64803839 P6153 Q1143396 @default.
- Q64803839 P6153 Q1188786 @default.
- Q64803839 P6153 Q30253969 @default.
- Q64803839 P6153 Q30254021 @default.
- Q64803839 P6153 Q30280151 @default.
- Q64803839 P6153 Q462576 @default.
- Q64803839 P6153 Q706177 @default.
- Q64803839 P8363 Q78089383 @default.